Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report released on Monday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Trading Down 37.5 %

Shares of NASDAQ CALA opened at $0.01 on Monday. Calithera Biosciences has a 1 year low of $0.01 and a 1 year high of $0.50. The company’s 50-day moving average is $0.02 and its 200 day moving average is $0.03.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.